Validation of a symptom diary for patients with gastro-oesophageal reflux disease

11Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Background: Symptom diaries are potentially attractive but, because of concerns about patient compliance, they have had limited use in clinical trials. We assessed the validity and responsiveness of a symptom diary for patients with gastro-oesophageal reflux disease. Methods: We included 215 patients with gastro-oesophageal reflux disease after starting treatment for 4 weeks with 40 mg esomeprazole once daily. Patients recorded whether they experienced night-time heartburn (yes/no), the severity of daytime heartburn on a scale from 1 (no heartburn) to 4 (severe heartburn) and their antacid use. Patients also completed a number of disease-specific and preference-based Health-related Quality of Life questionnaires at baseline and follow-up. Results: Consistent with a priori predictions, daytime heartburn showed moderate to strong correlations with the Quality of Life in Reflux and Dyspepsia questionnaire (0.36-0.67) and four scales of symptom severity (0.36-0.70) for baseline, follow-up and change scores, but low correlations with the Standard Gamble. Responsiveness of the daytime heartburn item was excellent with a mean change from baseline to follow-up of -1.3 (95% CI -1.4 to -1.1) and a standardized response mean of 1.33 while responsiveness of the daily antacid use item was moderate (mean change scores -1.8 tablets taken, 95% CI -2.3 to -1.3 and standardized response mean of 0.64). Conclusions: The excellent psychometric properties of this simple gastro-oesophageal reflux disease diary make it an attractive measure for future trials. © 2006 The Authors.

Cite

CITATION STYLE

APA

Puhan, M. A., Guyatt, G. H., Armstrong, D., Wiklund, I., Fallone, C. A., Heels-Ansdell, D., … Schünemann, H. J. (2006). Validation of a symptom diary for patients with gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics, 23(4), 531–541. https://doi.org/10.1111/j.1365-2036.2006.02775.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free